|
YALE COMPREHENSIVE CANCER CENTER
|
3P30CA016359-33S3
|
$600,000
|
$36,000
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
YALE COMPREHENSIVE CANCER CENTER
|
3P30CA016359-33S4
|
$75,000
|
$4,500
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
2P30CA138292-04
|
$1,492,676
|
$59,707
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-04S1
|
$74,993
|
$3,000
|
Curran, Walter
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-04S2
|
$149,680
|
$5,987
|
Curran, Walter
|
EMORY UNIVERSITY
|
|
Viruses and Cancer
|
5T32CA060395-17
|
$309,093
|
$185,456
|
Isom, Harriet
|
PENNSYLVANIA STATE UNIVERSITY
|
|
Viral Oncology Training Grant
|
5T32CA009111-35
|
$316,972
|
$95,092
|
CULLEN, BRYAN
|
DUKE UNIVERSITY
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-38S3
|
$4,555,705
|
$273,342
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-38S4
|
$74,854
|
$4,491
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-38S5
|
$139,989
|
$8,399
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-37S1
|
$50,000
|
$3,500
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-37S2
|
$246,000
|
$17,220
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-37S3
|
$74,999
|
$5,250
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
5P30CA014089-37
|
$6,285,726
|
$440,001
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
UNMC Eppley Cancer Center Support Grant
|
3P30CA036727-26S1
|
$74,440
|
$4,466
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
UNMC Eppley Cancer Center Support Grant
|
5P30CA036727-26
|
$1,427,680
|
$85,661
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
Transport of Large Molecules and Viral Vectors in Tumors: Effects of Cytotoxic an
|
5R01CA098706-09
|
$278,762
|
$139,381
|
BOUCHER, YVES
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Transcriptomic and Proteomic Approaches to Discovering Viral Causes for Human Hem
|
1R01CA170354-01
|
$349,040
|
$87,260
|
Chang, Yuan
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Training In Tumor Virology
|
5T32CA115299-07
|
$321,587
|
$128,635
|
Robertson, ERLE
|
UNIVERSITY OF PENNSYLVANIA
|
|
Towards a Mouse Model of Classical Hodgkin's Disease and PTLD
|
5R01CA098285-09
|
$501,376
|
$501,376
|
ALT, FREDERICK
|
IMMUNE DISEASE INSTITUTE, INC.
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-18S3
|
$4,829,857
|
$241,493
|
Rosen, Steven
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-18S4
|
$75,000
|
$3,750
|
Rosen, Steven
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-18S5
|
$76,389
|
$3,819
|
Rosen, Steven
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The interaction of Burkitt???s lymphoma cofactors EBV and Plasmodium
|
1F30CA168358-01
|
$31,920
|
$31,920
|
Wohlford, Eric
|
UPSTATE MEDICAL UNIVERSITY
|
|
TAS::75 0849::TAS INCREMENTAL FUNDING
|
261200800001E-51
|
$238,204,440
|
$31,160
|
HEIMBROOK, DAVID
|
SAIC-FREDERICK, INC.
|
|
Targets and functions of the Kaposi's Sarcoma associated herpesvirus microRNAs
|
5R00CA137860-03
|
$241,531
|
$241,531
|
Gottwein, Eva
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Targeting vFLIP for the treatment of KSHV-associated malignancies
|
5R01CA154228-02
|
$350,675
|
$350,675
|
CESARMAN, ETHEL
|
WEILL MEDICAL COLLEGE OF CORNELL UNIV
|
|
Targeting Tumorigenic Pathways in Glioblastoma with Oncolytic HSV
|
1R01CA160762-01A1
|
$356,356
|
$356,356
|
RABKIN, SAMUEL
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Targeting Kinases that Phosphorylate the KSHV LANA Chromatin Binding Domain
|
1R21CA171814-01
|
$211,410
|
$211,410
|
HAYWARD, S
|
JOHNS HOPKINS UNIVERSITY
|
|
T Cell Immunity in Endemic Burkitt Lymphoma
|
5R01CA134051-06
|
$443,858
|
$443,858
|
MOORMANN, ANN
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
Studying the role of KSHV-encoded microRNAs
|
5R01CA119917-05
|
$286,093
|
$286,093
|
RENNE, ROLF
|
UNIVERSITY OF FLORIDA
|
|
Study of Tumor Pathogenesis and Development of Therapies for AIDS Malignancies
|
ZIABC010885
|
$647,804
|
$583,024
|
Yarchoan, Robert
|
CCR (NCI)
|
|
Studies of HHV-8 vIL-6 Function
|
5R01CA076445-12
|
$349,564
|
$349,564
|
NICHOLAS, JOHN
|
JOHNS HOPKINS UNIVERSITY
|
|
Studies of Epstein-Barr Virus
|
5R37CA012055-40
|
$445,071
|
$445,071
|
MILLER, I.
|
YALE UNIVERSITY
|
|
Strategies to Enhance Virotherapy for Breast Cancer
|
5R01CA106671-09
|
$218,246
|
$218,246
|
ZHANG, XIAOLIU
|
UNIVERSITY OF HOUSTON
|
|
Stanford University Cancer Center
|
3P30CA124435-06S1
|
$74,997
|
$750
|
MITCHELL, BEVERLY
|
STANFORD UNIVERSITY
|
|
Stanford University Cancer Center
|
5P30CA124435-06
|
$3,091,618
|
$30,916
|
MITCHELL, BEVERLY
|
STANFORD UNIVERSITY
|
|
Selective Degradation of mRNA by Herpes Simplex Virus 1
|
5R01CA115662-08
|
$325,375
|
$325,375
|
Roizman, Bernard
|
UNIVERSITY OF CHICAGO
|
|
Role of the cellular microRNA, miR-155, in EBV type III latency signaling
|
5R01CA138268-04
|
$299,900
|
$299,900
|
FLEMINGTON, ERIK
|
TULANE UNIVERSITY OF LOUISIANA
|
|
ROLE OF Rac AND REACTIVE OXYGEN SPECIES IN KAPOSI'S SARCOMA VIRAL ONCOGENESIS
|
5R01CA136387-03
|
$437,003
|
$437,003
|
MESRI, ENRIQUE
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
Role of gammaherpesvirus lytic replication-associated genes in the establishment
|
5R01CA139984-03
|
$294,868
|
$294,868
|
Tibbetts, Scott
|
UNIVERSITY OF FLORIDA
|
|
Role of B Cells in Murine Gammaherpesvirus-68 Latency
|
5R01CA095318-08
|
$330,795
|
$330,795
|
SPECK, SAMUEL
|
EMORY UNIVERSITY
|
|
Rhesus HHV-8 homologue in AIDS-related malignancies
|
5R01CA075922-16
|
$689,049
|
$689,049
|
WONG, SCOTT
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
|
Research Training in Neuro-Oncology
|
5T32CA009574-25
|
$241,622
|
$12,081
|
GROSSMAN, STUART
|
JOHNS HOPKINS UNIVERSITY
|
|
Research Management and Support - Total
|
RMS2012 [E]
|
$374,919,382
|
$18,746
|
N/A
|
(NCI)
|
|
Regulation of the Tumor Microenvironment by KSHV
|
5R01CA142362-03
|
$296,881
|
$296,881
|
PARSONS, CHRISTOPHER
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Regulation of the KSHV Latent Promoter
|
3R01CA109232-08S1
|
$64,986
|
$64,986
|
Dittmer, Dirk
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
Regulation of the KSHV Latent Promoter
|
5R01CA109232-08
|
$234,401
|
$234,401
|
DITTMER, DIRK
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
Regulation of replication and latency EBV EBNAs
|
5R37CA042245-27
|
$356,292
|
$356,292
|
HAYWARD, S
|
JOHNS HOPKINS UNIVERSITY
|
|
Regulation of KSHV Latency
|
5R01CA117830-07
|
$291,966
|
$291,966
|
LIEBERMAN, PAUL
|
WISTAR INSTITUTE
|
Total relevant funding to Herpes - Other for this search: $46,738,132
|